The influence of nilvadipin on lipid metabolism and platelet aggregation

被引:0
作者
Hirayama, A [1 ]
Handa, H [1 ]
Honjo, M [1 ]
Uehara, S [1 ]
Itagaki, Y [1 ]
Izumiyama, S [1 ]
机构
[1] Tonan Clin, Inner Unit, Tonan Byoin Naika, Sapporo, Hokkaido, Japan
来源
PERFUSION | 1999年 / 12卷 / 05期
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:228 / 232
页数:5
相关论文
共 9 条
[1]  
BIELMANN P, 1981, CURR THER RES, V30, P556
[2]   MECHANISM OF PROTECTION FROM ATHEROSCLEROSIS BY VERAPAMIL IN THE CHOLESTEROL-FED RABBIT [J].
BLUMLEIN, SL ;
SIEVERS, R ;
KIDD, P ;
PARMLEY, WW .
AMERICAN JOURNAL OF CARDIOLOGY, 1984, 54 (07) :884-889
[3]  
CORSINI A, 1986, PHARMACOL RES, V18, P1
[4]  
HORIUCHI I, 1986, GERIAT MED, V24, P1671
[5]   CHOLESTEROL IN THE PREDICTION OF ATHEROSCLEROTIC DISEASE - NEW PERSPECTIVES BASED ON THE FRAMINGHAM STUDY [J].
KANNEL, WB ;
CASTELLI, WP ;
GORDON, T .
ANNALS OF INTERNAL MEDICINE, 1979, 90 (01) :85-91
[6]  
LEREN P, 1982, J CARDIOVASC PHAR S2, V4, P222
[7]  
MUTO S, 1986, DAI 18 KAI NIH DOM G
[8]  
NAKAMURA H, 1986, GENDAI IRYO, V18, P201
[9]   VERAPAMIL ENHANCES RECEPTOR-MEDIATED ENDOCYTOSIS OF LOW-DENSITY LIPOPROTEINS BY AORTIC-CELLS IN CULTURE [J].
STEIN, O ;
LEITERSDORF, E ;
STEIN, Y .
ARTERIOSCLEROSIS, 1985, 5 (01) :35-44